Contribution of Cdc42 to Cholesterol Efflux in Fibroblasts from Tangier Disease and Werner Syndrome

Methods in Enzymology

Volumn 439, Issue , 2008, Pages 159-169

  Hirano, Ken ichi ^a   Ikegami, Chiaki ^b   Zhang, Zhongyan ^c  

^a OSAKA UNIVERSITY   (Japan)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; ACTIN; CHOLESTEROL; CYTOSKELETON PROTEIN; PHOSPHOLIPID; PROTEIN CDC42; ABC TRANSPORTER;

ATHEROSCLEROSIS; CELL CULTURE; CELL ISOLATION; EFFUSION; FIBROBLAST; HUMAN; INTRACELLULAR TRANSPORT; LIPID TRANSPORT; MACROPHAGE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; TANGIER DISEASE; WERNER SYNDROME; WISKOTT ALDRICH SYNDROME; ANIMAL; ARTICLE; CELL STRAIN COS1; CERCOPITHECUS; DOG; LIPID METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SECRETION;

ADENOVIRIDAE;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CDC42 GTP-BINDING PROTEIN; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; CHOLESTEROL; COS CELLS; DOGS; FIBROBLASTS; HUMANS; LIPID METABOLISM; MACROPHAGES; TANGIER DISEASE; WERNER SYNDROME;

EID: 45549084076     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(07)00412-0     Document Type: Review

References (28)

1. Brosh Jr. R.M., and Bohr V.A. Roles of the Werner syndrome protein in pathways required for maintenance of genome stability. Exp. Gerontol. 37 (2002) 491-506
2. Chen L., and Oshima J. Werner syndrome. J. Biomed. Biotechnol 2 (2002) 46-54
3. Cutler R.G., Kelly J., Storie K., Pedersen W.A., Tammara A., Hatanpaa K., Troncoso J.C., and Mattson M.P. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc. Natl. Acad. Sci. USA 101 (2004) 2070-2075
4. Diederich W., Orso E., Drobnik W., and Schimitz G. Apolipoprotein AI and HDL3 inhibit spreading of primary human monocytes through a mechanism that involves cholesterol depletion and regulation of Cdc42. Atherosclerosis 159 (2001) 313-324
5. Drobnik W., Liebisch G., Biederer C., Trumbach B., Rogler G., Muller P., and Schmitz G. Growth and cell cycle abnormalities of fibroblasts from Tangier disease patients. Arterioscler. Thromb. Vasc. Biol. 19 (1998) 28-38
6. Hall A. Rho GTPases and the actin cytoskeleton. Science 279 (1998) 509-514
7. Hirano K., Matsuura F., Tsukamoto K., Zhang Z., Matsuyama A., Takaishi K., Komuro R., Suehiro T., Yamashita S., Takai Y., and Matsuzawa Y. Decreased expression of a member of the Rho GTPase family, Cdc42Hs, in cells from Tangier disease: The small G protein may play a role in cholesterol efflux. FEBS Lett. 484 (2000) 275-279
8. Hirano K., Yamashita S., Sakai N., and Matsuzawa Y. Low and high HDL syndrome. "Encylopedia of Endocrine Disease," Vol. 3 (2004), Elsevier, San Diego 199-205
9. Hou M., Xia M., Zhu H., Wang Q., Li Y., Xiao Y., Zhao T., Tang Z., Ma J., and Ling W. Lysophosphatidylcholine promotes cholesterol efflux from mouse macrophage foam cells via PPARgamma-LXRalpha-ABCA1-dependent pathway associated with apoE. Cell Biochem. Funct. 25 (2007) 33-44
10. Johnson F.B., Sinclair D.A., and Guarente L. Molecular biology of aging. Cell 96 (1999) 291-302
11. Joseph J.A., Villalobos-Molina R., Denisova N., Erat S., Jimenez N., and Strain J. Increased sensitivity to oxidative stress and the loss of muscarinic receptor responsiveness in senescence. Ann. N.Y. Acad. Sci. 786 (1996) 112-119
12. Kodama A., Takaishi K., Nakano K., Nishioka H., and Takai Y. Involvement of Cdc42 small G protein in cell-cell adhesion, migration, and morphology of MDCK cells. Oncogene 18 (1999) 3996-4006
13. Koseki M., Hirano K., Masuda D., Ikegami C., Tanaka M., Ota A., Sandoval J.C., Nakagawa-Toyama Y., Sato S.B., Kobayashi T., Shimada Y., Ohno-Iwashita Y., et al. Increased lipid rafts and accelerated lipopolysaccharide-induced tumor necrosis factor-alpha secretion in Abca1-deficient macrophages. J. Lipid Res. 48 (2007) 299-306
14. Matsuura F., Hirano K., Koseki M., Ohama T., Matsuyama A., Tsujii K., Komuro R., Nishida M., Sakai N., Hiraoka H., Nakamura T., and Yamashita S. Familial massive tendon xanthomatosis with decreased high-density lipoprotein-mediated cholesterol efflux. Metabolism 54 (2005) 1095-1101
15. Nishida Y., Hirano K., Tsukamoto K., Nagano M., Ikegami C., Roomp K., Ishihara M., Sakane N., Zhang Z., Tsujii Ki K., Matsuyama A., Ohama T., et al. Expression and functional analyses of novel mutations of ATP-binding cassette transporter-1 in Japanese patients with high-density lipoprotein deficiency. Biochem. Biophys. Res. Commun. 290 (2002) 713-721
16. Nofer J.R., Feuerborn R., Levkau B., Sokoll A., Seedorf U., and Assmann G. Involvement of Cdc42 signaling in apo A-I-inducedcholesterol efflux. J. Biol. Chem. 278 (2003) 53055-53062
17. Nofer J.R., Remaley A.T., Feuerborn R., Wolinnska I., Engel T., von Eckardsterin A., and Assmann G. Apolipoprotein A-I activates Cdc42 Signalling through the ABCA1 transporter. J. Lipid Res. 47 (2006) 794-803
18. Ohama T., Hirano K., Zhang Z., Aoki R., Tsujii K., Nakagawa-Toyama Y., Tsukamoto K., Ikegami C., Matsuyama A., Ishigami M., Sakai N., Hiraoka H., et al. Dominant expression of ATP-binding cassette transporter-1 on basolateral surface of Caco-2 cells stimulated by LXR/RXR ligands. Biochem. Biophys. Res. Commun. 296 (2002) 625-630
19. Orso E., Broccardo C., Kaminski W.E., Böttcher A., Liebisch G., Drobnik W., Götz A., Chambenoit O., Diederich W., Langmann T., Spruss T., Luciani M.F., et al. Transport of lipids from Golgi to plasma membrane is defective in Tangier disease patients and Abc1-deficient mice. Nat. Genet. 24 (2000) 192-196
20. Soccio R.E., and Breslow J.L. Intracellular cholesterol transport. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1150-1160
21. Tahara S., Matsuo M., and Kaneko T. Age-related changes in oxidative damage to lipids and DNA in rat skin. Mech. Ageing Dev. 122 (2001) 415-426
22. Takai Y., Sasaki T., and Matozaki T. Small GTP-binding proteins. Physiol. Rev. 81 (2001) 153-208
23. Tsukamoto K., Hirano K., Tsujii K., Ikegami C., Zhongyan Z., Nishida Y., Ohama T., Matsuura F., Yamashita S., and Matsuzawa Y. ATP-binding cassette transporter-1 (ABCA1) induces rearrangement of actin cytoskeleton through possible interaction between ABCA1 and Cdc42. Biochem. Biophys. Res. Commun. 287 (2001) 757-765
24. Tsukamoto K., Hirano K., Yamashita S., Sakai N., Ikegami C., Zhang Z., Matsuura F., Hiraoka H., Matsuyama A., Ishigami M., and Matsuzawa Y. Retarded intracellular lipid transport associated with reduced expression of a member of Rho-GTPases, Cdc42, in human aged skin fibroblasts: a possible function of Cdc42 to mediated intracellular lipid transport. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 1899-1904
25. Utech M., Höbbel G., Rust S., Reinecke H., Assmann G., and Walter M. Accumulation of RhoA, RhoB, RhoG, and Rac1 in fibroblasts from Tangier disease subjects suggests a regulatory role of Rho family proteins in cholesterol efflux. Biochem. Biophys. Res. Commun. 280 (2001) 229-236
26. Zanotti I., Potì F., Favari E., Steffensen K.R., Gustafsson J.A., and Bernini F. Pitavastatin effect on ATP binding cassette A1-mediated lipid efflux from macrophages: evidence for liver X receptor (LXR)-dependent and LXR-independent mechanisms of activation by cAMP. J. Pharmacol. Exp. Ther. 317 (2006) 395-401
27. Zhang Z., Hirano K., Tsukamoto K., Ikegami C., Koseki M., Saijo K., Ohno T., Sakai N., Hiraoka H., Shimomura I., and Yamashita S. Defective cholesterol efflux in Werner syndrome fibroblasts and its phenotypic correction by Cdc42, a RhoGTPase. Exp. Gerontol. 40 (2005) 286-294
28. Zhang Z., Yamashita S., Hirano K., Nakagawa-Toyama Y., Matsuyama A., Nishida M., Sakai N., Fukasawa M., Arai H., Miyagawa J., and Matsuzawa Y. Expression of cholesteryl ester transfer protein in human atherosclerotic lesions and its implication in reverse cholesterol transport. Atherosclerosis 159 (2001) 67-75